Trial Profile
Study to Assess the Pharmacodynamic Effects of Repeated Oral Doses of SAR247799 on Endothelial Function in Male and Female Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2020
Price :
$35
*
At a glance
- Drugs SAR 247799 (Primary) ; Acetylcholine; Sildenafil
- Indications Coronary artery disease
- Focus First in man; Pharmacodynamics
- Sponsors Sanofi
- 30 Oct 2020 Results published in the British Journal of Clinical Pharmacology
- 08 Jan 2019 Status changed from recruiting to completed.
- 29 Nov 2018 Planned End Date changed from 10 Dec 2018 to 21 Dec 2018.